Please note that a "1" following a contributor's name indicates that he or she has no relationships to disclose. A "2" indicates that the contributor has disclosed relationships.
The following committee members, reviewers, and ACP staff members have disclosed relationships with commercial companies:
St. Jude Medical, Rhythm Management
UpToDate
Pfizer, Merck, AstraZeneca
Philips Medical Systems
RoyaltiesUpToDate, Saunders
GE Healthcare, FDA
Speakers BureauOtuksu, Merck, Solvay
Research Grants/ContractsNIH
Biotronik, Inc.
Abbott Vascular, AbioMed
Research Grants/ContractsCardioMems, Cordis, Abbott Vascular, St. Jude, GlaxoSmithKline, Maquet/Data Scope, Roche, AGA Medical, AbioMed
Merck and Company
First Aid Board Review Book Series
Evalve, Inc., Edwards Lifesciences, Abbott Vascular, Gilead Sciences
OtherExpert reviewer for legal case of infective endocarditis
Please note that a "1" following a contributor's name indicates that he or she has no relationships to disclose. A "2" indicates that the contributor has disclosed relationships.
The following committee members, reviewers, and ACP staff members have disclosed relationships with commercial companies:
Celgene, Pfizer, Merck, Schering-Plough, Abbott, Johnson and Johnson, Medtronic, McKesson, Amgen
University of Alabama at Birmingham
Research Grants/ContractsUnited Therapeutics, NIH
ConsultantshipGilead Sciences Inc.
Speakers BureauEncysive Pharmaceuticals
Centocor, Johnson and Johnson
Altor Bioscience, Bristol-Myers Squibb, Pfizer
ConsultantshipSiemens
Merck and Company
Figures shown in Self-Assessment Test Items 22, 28, and 54 appear courtesy of Dr. Barbara Mathes.
Figures shown in Self-Assessment Test Items 7, 55, and 74 appear courtesy of Dr. David Crosby.
Figures shown in Self-Assessment Test Items 38 and 66 are reprinted with permission from Physicians Information and Education Resource (ACP PIER). Philadelphia, PA: American College of Physicians.
Please note that a "1" following a contributor's name indicates that he or she has no relationships to disclose. A "2" indicates that the contributor has disclosed relationships.
The following committee members, reviewers, and ACP staff members have disclosed relationships with commercial companies:
Pfizer, Amgen, Exelixis, Innovative Technologies
Board MemberAmerican Thyroid Association; FDA, Endocrine Advisory Committee
OtherUpToDate, Medscape, Endocrine Society
Reviewer for AAAS Research Competitiveness Program
HonorariaMedlink Neurology
Speakers BureauMedical Education Speakers Network
Merck
Takeda, Merck, Amylin, Medtronic, Boehringer Ingelheim
HonorariaNovoNordisk
Research Grants/ContractsBoehringer Ingelheim, Eli Lilly
OtherEndocrine Society, UpToDate
Novartis, Ipsen, Pfizer, Genentech
ConsultantshipPfizer
Speakers BureauIpsen
UpToDate
Merck and Company
Please note that a "1" following a contributor's name indicates that he or she has no relationships to disclose. A "2" indicates that the contributor has disclosed relationships.
The following committee members, reviewers, and ACP staff members have disclosed relationships with commercial companies:
Idera Pharmaceuticals, Inc.
Novartis
HonorariaNational Board of Medical Examiners
Eli Lilly and Company Retiree
Stock Options/HoldingsEli Lilly, Abbott, Isis
ConsultantshipMarcaida, Biogen Idec
Sanofi-Aventis, NovoNordisk
Speakers BureauSanofi-Aventis, NovoNordisk
Boston Scientific
Research Grants/ContractsChiRhoClin, Inc.
Foundation for Informed Medical Decision Making
RoyaltiesUpToDate
Bristol Myers-Squibb: Virology M.D. Fellows Research Program Grant
Genomic Health, Inc.
Research Grants/ContractsOlympus America, Beneo-Orafti Group, Bayer Healthcare, Fujinon, Inc., Boston Scientific, AstraZeneca
HonorariaAmerican School of Oncology
RoyaltiesExact Sciences
AstraZeneca, Fujinon, Takeda Pharmaceuticals, Given Imaging, NIH, American College of Gastroenterology
Abbott, Elan Pharmaceuticals, Warner-Chilcott, Allos Pharmaceuticals, Janssen
HonorariaAbbott, UCB, Merck
Research Grants/ContractsAbbott, UCB, Warner-Chilcott, Salix
OtherRisk Prediction Model (Patent Holder)
Merck and Company
Salix Pharmaceuticals, Merck, Bristol-Myers Squibb
OtherAASLD (Chair, Practice Guidelines Committee)
Please note that a "1" following a contributor's name indicates that he or she has no relationships to disclose. A "2" indicates that the contributor has disclosed relationships.
The following committee members, reviewers, and ACP staff members have disclosed relationships with commercial companies:
Eli Lilly & Co. (Retiree)
Stock Options/HoldingsEli Lilly, Abbott, Isis
ConsultantshipMarcadia, Biogen Idec
AstraZeneca
Stock Options/HoldingsAbbott Laboratories
Celgene, Cephalon Oncology, GlaxoSmithKline
Foundation for Informed Medical Decision Making
Research Grants/ContractsNIH
RoyaltiesUpToDate
Oakstone Medical Publishing
Novartis (spouse), Celgene (spouse), Millenium (spouse)
Bertino Consulting
Merck and Company
Celgene
The figures shown in Self-Assessment Test Item 29, Item 148, and Item 61 appear courtesy of Edward A. Jaeger, MD, Jefferson Medical College, Wills Eye Institute, Philadelphia, PA.
The figure shown in Self-Assessment Test Item 163 is reprinted with permission from Physicians’ Information and Education Resource (ACP PIER). Philadelphia, PA: American College of Physicians.
Please note that a "1" following a contributor's name indicates that he or she has no relationships to disclose. A "2" indicates that the contributor has disclosed relationships.
The following committee members, reviewers, and ACP staff members have disclosed relationships with commercial companies:
Celgene, Cephalon Oncology, GlaxoSmithKline
Alexion Pharmaceuticals
Medtronic, St. Jude Corporation
HonorariaAstellas Pharmaceutical, St. Jude Corporation
CSL Behring, NovoNordisk, Bayer
Speakers BureauNovoNordisk
Beckman Coulter
Novartis (spouse), Celgene (spouse), Millenium (spouse)
NeoStem, Amorcyte, TetraLogics
Board MemberCancer Genetics
Roche, Genentech, Bristol-Myers Squibb, Imclone, Merck, Amgen, Pfizer, Novartis, Genzyme, Genomic Health
HonorariaJohnson and Johnson
Merck and Company
Sanofi-Aventis
Teva, Akebia, Fibrogen, Celgene
Sanofi-Aventis, GlaxoSmithKline, Eisai, Inc., Educational Concepts Group, Inc., Medical Communications Media, Inc., OrthoBiotech
Research Grants/ContractsBristol-Myers Squibb, Sanofi-Aventis
ConsultantshipSanofi-Aventis, Daiichi-Sankyo, Johnson and Johnson, Eisai, Inc.
Bristol-Myers Squibb
Millennium Pharmaceuticals, Celgene
ConsultantshipMedImmune
Research Grants/ContractsMerck, Centocor OrthoBiotech, Pfizer
GlaxoSmithKline, Amgen, Johnson and Johnson
Please note that a "1" following a contributor's name indicates that he or she has no relationships to disclose. A "2" indicates that the contributor has disclosed relationships.
The following committee members, reviewers, and ACP staff members have disclosed relationships with commercial companies:
Idera Pharmaceuticals
Stock Options/HoldingsIdera Pharmaceuticals
Novartis
Cubist, Sanofi-Pasteur
Cubist, Merck, Pfizer, OrthoMcNeil
ConsultantshipMerck, Pfizer, OrthoMcNeil, Forest Pharmaceuticals, Theradoc
Research Grants/ContractsMerck, Pfizer, Cubist, Sage Products, Inc.
UpToDate
Merck, Pfizer, T2 BioSystems, Astellas
RoyaltiesUpToDate
OtherPfizer, Merck
Merck and Company
Food and Drug Administration
Research Grants/ContractsUpToDate
OtherNIH, Infectious Diseases Society of America
Figure shown in Self-Assessment Test Item 25 reproduced with permission from the Massachusetts Medical Society. From Baker DJ, Reboli AC. [Images in Clinical Medicine]. N Engl J Med. 1997;998. Copyright © 1997 Massachusetts Medical Society.
Please note that a "1" following a contributor's name indicates that he or she has no relationships to disclose. A "2" indicates that the contributor has disclosed relationships.
The following committee members, reviewers, and ACP staff members have disclosed relationships with commercial companies:
Celgene, Pfizer, Merck, Schering-Plough, Abbott, Johnson and Johnson, Medtronic, McKesson, Amgen
Roche
Beckman Coulter
Medtronic
Case Western Reserve University
Research Grants/ContractsNIH
ConsultantshipFDA, GE HealthCare, Solvay
Speakers BureauAstraZeneca, Novartis, Otuska
Altor Bioscience, Bristol-Myers Squibb, Pfizer
ConsultantshipSiemens
Merck and Company
Pfizer, Novartis, Nicox, Medtronic
Speakers BureauASN, ASH
Research Grants/ContractsNIH
Please note that a "1" following a contributor's name indicates that he or she has no relationships to disclose. A "2" indicates that the contributor has disclosed relationships.
The following committee members, reviewers, and ACP staff members have disclosed relationships with commercial companies:
Medtronic, Inc.
GlaxoSmithKline
Speakers BureauGlaxoSmithKline
Direct One Communications
Research Grants/ContractsBayer Schering Pharma
GlaxoSmithKline, Merck, OrthoMcNeil
Avanir Pharmaceuticals, Inc.
HonorariaAvanir Pharmaceuticals, Inc.
Speakers BureauAvanir Pharmaceuticals, Inc.
Merck and Company
Cardionet
Churchill-Livingstone
HonorariaCelgene, Millenium
ConsultantshipCelgene
Speakers BureauCelgene
The figure shown in Self-Assessment Test item 7 is adapted with permission from Laforest C, Selva D, Crompton J, Leibovitch I. Clinical observations: Entopic phenomenon as initial presentation of acute myelogenous leukemia. Ann Intern Med. 2005;143(11):847. [PMID: 16330805]
The figure shown in Self-Assessment Test item 90 is adapted with permission from Virtual Dx, Physical Examination Findings, item 23. Copyright 2010 American College of Physicians. All Rights Reserved. Available (to program subscribers) at: http://virtualdx.acponline.org/self-assessment/questions/pef_q023. Accessed March 19, 2012.
Please note that a "1" following a contributor's name indicates that he or she has no relationships to disclose. A "2" indicates that the contributor has disclosed relationships.
The following committee members, reviewers, and ACP staff members have disclosed relationships with commercial companies:
ResMed Foundation, Ventus Medical
Boehringer Ingelheim
PTC Therapeutics, Gilead, Pfizer, Novartis Research Grant, Vertex, DSMB
Advisory BoardNovartis, Boehringer Ingelheim, Pfizer, Gilead, Bayer
Speakers BureauNovartis, Boehringer Ingelheim, Pfizer, Gilead, Milan
Research Grants/ContractsCystic Fibrosis Foundation, Gilead, Vertex, CFF, Novartis, Bayer, MPEX, Transave, Boehringer Ingelheim
Merck Pharmaceuticals
Asthmatx
Research Grants/ContractsGlaxoSmithKline, Merck, Genentech
Merck and Company
InterMune
Research Grants/ContractsInterMune, Celgene, Actelion, Centocor, Genzyme, SanofiAventis, Boehringer Ingelheim
Please note that a "1" following a contributor's name indicates that he or she has no relationships to disclose. A "2" indicates that the contributor has disclosed relationships.
The following committee members, reviewers, and ACP staff members have disclosed relationships with commercial companies:
Biotronik
Human Genome Sciences, Genentech, Merck Serono, UCB Pharma, Eli Lilly, Anthera
HonorariaBristol-Myers Squibb
Celgene, Pfizer, Merck, Schering-Plough, Abbott, Johnson and Johnson, Medtronic, McKesson, Amgen
Amgen, Pfizer, The Rheumatology Education Group
Adamas Pharmaceuticals, Antisoma (Xanthus), Bristol-Myers Squibb, Canyon Pharmaceuticals, CE3, Cubist, Dominion Diagnostics, InterMune, Inc., Population Council, Sirtris (now GlaxoSmithKline), ViroPharma
Takeda Inc.
Merck and Company
Genzyme Corporation
Gilead Pharmaceuticals